Reviving an ancient human gene that prevents gout and fatty liver disease, scientists at Georgia State University have marked ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

In 2016, Trevor Martin, a biology Ph.D. at Stanford, was growing restless. He’d fallen in love with synthetic biology, where discoveries were being made weekly, but was frustrated with the lab’s ...

CREME is a virtual laboratory that allows scientists to simulate specific decreases in gene activity. It offers a powerful new tool for identifying and understanding important parts of the genome. And ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

A systematic sweep of viral genomes has revealed a trove of potential CRISPR-based genome-editing tools. CRISPR–Cas systems are common in the microbial world of bacteria and archaea, where they often ...

He Jiankui, PhD, a Chinese scientist who sparked controversy in 2018 after claiming to have genetically modified two human embryos, is on a new scientific endeavor: trying to develop a therapy for ...